Two cases of late-diagnosed non-surgical hypoparathyroidism
pdf (Українська)

Keywords

non-surgical hypoparathyroidism
CATCH 22
22q11.2 deletion syndrome
TBX1-related DiGeorge syndrome
LZTR1-related schwannomatosis
CLCN1-related myotonia
Graves’ disease
Chornobyl

How to Cite

Yukhymchuk, O., Ryabova, Y., Kolesnik, T., Fedash-Kirsanov, O., Makarenko, V., & Khalangot, M. (2025). Two cases of late-diagnosed non-surgical hypoparathyroidism. Endokrynologia, 30(1), 70-77. https://doi.org/10.31793/1680-1466.2025.30-1.70

Abstract

Abstract. Hypoparathyroidism is characterized by low parathyroid hormone levels, low calcium levels, and high phosphate levels in the blood. The most common cause is neck surgery. Non-surgical hypoparathyroidism (Ns-HypoPT) can have various causes, including genetic ones. The most common genetic cause of Ns-HypoPT is the loss of the q11 region (22q11) on chromosome 22, which results in hypoplasia of the parathyroid glands. 22q11 syndrome is also known as DiGeorge syndrome (DGS). The acronym «CATCH  22» refers to the five clinical manifestations of DGS: Cardiac defects; Abnormal facies – facial dysmorphia; Thymic hypoplasia; Cleft palate; Hypocalciemia (HC). Diagnosis of DGS can be complicated due to the phenotype variation. DGS is suspected in the presence of at least one CATCH22 sign, molecular genetic methods confirm or refute the diagnosis. The publication presents two cases of Ns-HypoPT in adults who were not diagnosed in a timely manner. In both cases, HC with a decrease in PTH levels without a surgical history indicates Ns-HypoPT. Using nucleotide sequence analysis and
deletion/duplication testing of a panel of 2,211 genes in case №1, pathogenic variants were identified in three genes: TBX1 (associated with autosomal dominant DGS); LZTR1 (associated with autosomal dominant schwannomatosis and autosomal dominant and autosomal recessive Noonan syndrome); CLCN1 (associated with autosomal dominant and recessive congenital myotonia). Case 1 is characterized by the combination of DGS and Graves’ disease. Despite the different etiology of Ns-HypoPT (in case 1 it is a component of DGS, and in case 2 the etiology has not yet been established), in both cases HC was detected late and was treated ineffectively for a long time. The use of calcitriol [1,25 (OH)2 D3], the active form of vitamin D3, at a dosage of 1.25 μg/day (case 1) and 1.75 μg/day (case 2) increased calcium levels and reduced HC  ymptoms.

https://doi.org/10.31793/1680-1466.2025.30-1.70
pdf (Українська)

References

Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med. 2000 Dec 21;343(25):1863-75. doi: 10.1056/NEJM200012213432508.

Hejlesen J, Underbjerg L, Gjørup H, Bloch-Zupan A, Sikjaer T, Rejnmark L, et al. Dental findings in patients with non-surgical hypoparathyroidism and pseudohypoparathyroidism: a systematic review. Front Physiol. 2018 Jun 19;9:701. doi: 10.3389/ fphys.2018.00701.

Cooper MD, Peterson RDA, Good RA. A new concept of the cellular basis of immunity. J Pediatr. 1965;67(5):907-8. doi: 10.1016/S0022-3476(65)81796-6.

Kirkpatrick JA Jr, DiGeorge AM. Congenital absence of the thymus. Am J Roentgenol Radium Ther Nucl Med. 1968 May;103(1):32-7. doi: 10.2214/ajr.103.1.32.

de la Chapelle A, Herva R, Koivisto M, Aula P. A deletion in chromosome 22 can cause DiGeorge syndrome. Hum Genet. 1981;57(3):253-6. doi: 10.1007/BF00278938.

Agergaard P, Hebert A, Sørensen KM, Østergaard JR, Olesen C. Can clinical assessment detect 22q11.2 deletions in patients with cardiac malformations? A review. Eur J Med Genet. 2011 Jan-Feb;54(1):3-8. doi: 10.1016/j.ejmg.2010.09.016.

Wilson DI, Burn J, Scambler P, Goodship J. DiGeorge syndrome: part of CATCH 22. J Med Genet. 1993 Oct;30(10):852-6. doi: 10.1136/jmg.30.10.852.

Heller J. Catch-22. London: Jonathan Cape; 1962.

Miller KA. FISH diagnosis of 22q11.2 deletion syndrome. Newborn Infant Nursing Rev. 2008;8(1):e11-9. doi: 10.1053/j. nainr.2007.12.006.

McDonald-McGinn DM, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore). 2011, Jan; 90(1):1-18. doi: 10.1097/MD.0b013e3182060469.

Bohrer T, Pasteur I, Lyutkevych O, Fleischmann P, Tronko M. Permanenter hypoparathyreoidismus infolge von schilddrüsenkarzinomoperationen nach Tschernobyl in der Ukraine [Permanent hypoparathyroidism due to thyroid cancer surgical procedures in patients exposed to radiation in the Chernobyl, Ukraine, nuclear reactor accident]. Dtsch Med Wochenschr. 2005 Nov 4;130(44):2501-6. German. doi: 10.1055/s-2005-918594.

Bohrer T, Pasteur I, Lyutkevych O, Fleischmann P, Sitter H, Donner-Banzhoff N, et al. Permanent postoperative hypoparathyroidism. An epidemiological clinical study using a new questionnaire instrument. J Ukrainian Acad Sci. 2003;9(3):476-94.

Ґанонґ ВФ. Фізіологія людини: Підручник. Переклад з англ. Наук. ред. перекладу М. Гжегоцький, В. Шевчук, О. Заячківська. Львів: БаК, 2002. – 784 с. (Ganong VF. Human physiology: textbook. Translated from English. Scientific ed. translation M. Gzhehotsky, V. Shevchuk, O. Zayachkivska. Lviv: BaK, 2002. – 784 p. Ukrainian).

Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab. 2006 Aug;91(8):2843-50. doi: 10.1210/jc.2005-2611.

Dodos K, Kalamara VT, Georgakopoulou VE, Kavoura P. Primary hypoparathyroidism in a patient with sarcoidosis: a case report. Cureus. 2024 Sep 16;16(9):e69504. doi: 10.7759/cureus.69504.

Downloads

Download data is not yet available.